J2783 HCPCS code: Injection, rasburicase, 0.5 mg
J2783 is the HCPCS Level II code for injection, rasburicase, 0.5 mg. In 2024 Medicare paid an average of $287.35 per service for J2783 across 18,739 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 60 per day on outpatient hospital claims. Medicare volume fell 36% from 2022 to 2024 (29,193 to 18,739 services). In 2024, about 502 clinicians billed Medicare for J2783 for 697 beneficiaries; California, New York, Tennessee accounted for 46% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2004-01-01 |
| Last action effective | 2004-01-01 |
Who bills J2783 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 502 |
| Medicare beneficiaries | 697 |
| States with claims | 19 |
| Share of services in top 3 states (California, New York, Tennessee) | 46% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2783, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 29,193 | 895 | $320.74 | $255.98 |
| 2023 | 22,280 | 805 | $341.30 | $271.93 |
| 2024 | 18,739 | 697 | $360.67 | $287.35 |
States with the most J2783 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 3,289 | $289.52 |
| New York | 2,476 | $286.35 |
| Tennessee | 2,036 | $288.59 |
| Maryland | 1,971 | $289.79 |
| Florida | 1,116 | $288.04 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 60 | Prescribing Information |
| practitioner claims | 60 | Prescribing Information |
What changed for J2783
- 2004-01-01: J2783 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2783?
J2783 is the HCPCS Level II code for injection, rasburicase, 0.5 mg. Short descriptor: "Rasburicase".
How much does Medicare pay for J2783?
In 2024, the average Medicare payment was $287.35 per service (average allowed $360.67).
Does Medicare cover J2783?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J2783 can be billed per day?
60 on outpatient hospital claims; 60 on practitioner claims (NCCI medically unlikely edits).
Related J27 codes
- J2700 — Injection, oxacillin sodium, up to 250 mg
- J2704 — Injection, propofol, 10 mg
- J2710 — Injection, neostigmine methylsulfate, up to 0.5 mg
- J2720 — Injection, protamine sulfate, per 10 mg
- J2724 — Injection, protein c concentrate, intravenous, human, 10 iu
- J2725 — Injection, protirelin, per 250 mcg
- J2730 — Injection, pralidoxime chloride, up to 1 gm
- J2760 — Injection, phentolamine mesylate, up to 5 mg
- J2765 — Injection, metoclopramide hcl, up to 10 mg
- J2770 — Injection, quinupristin/dalfopristin, 500 mg (150/350)
- J2777 — Injection, faricimab-svoa, 0.1 mg
- J2778 — Injection, ranibizumab, 0.1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2783
- Watch J2783 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2783
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.